Social Communication Disorder

1

Review clinical trials related to Social Communication Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD

The purpose of this study is to evaluate the safety of NDTx-03 used together with treatment as usual (TAU) and to determine whether NDTx-03 plus TAU is more effective than TAU alone in improving social situation recognition and interaction in children and adolescents with autism spectrum disorder (ASD) or social communication disorder (SCD).

Participants needed: 156
Trial details
Age: 10-18Biological sex: AllType: InterventionalSponsor: Neudive Inc.Updated: Aug 18, 2026Locations: 6
Eligibility criteria

Children and adolescents aged 10 to 18 years. [+9]

Clinically significant behavioral problems, emotional regulation problems, psych... [+8]